Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G E Vrentzos

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Current Medicinal Chemistry|July 14, 2007
Dyslipidemia as a risk factor for erectile dysfunctionG E Vrentzos, K I Paraskevas, D P Mikhailidis
Current Pharmaceutical Design|October 8, 2003
The effects of antihypertensive therapy on haemostatic parametersE S Ganotakis, J A Papadakis, G E Vrentzos, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|February 8, 2005
Wild chamomile (Matricaria recutita L.) mouthwashes in methotrexate-induced oral mucositisE E Mazokopakis, G E Vrentzos, J A Papadakis, et al.
Journal of Human Nutrition and Dietetics : the Official Journal of the British Dietetic Association|March 15, 2006
Serum homocysteine concentration as a marker of nutritional status of healthy subjects in Crete, GreeceG E Vrentzos, J A Papadakis, N Malliaraki, et al.
International Journal of Clinical Practice|September 20, 2007
Predicting coronary heart disease risk using the Framingham and PROCAM equations in dyslipidaemic patients without overt vascular diseaseG E Vrentzos, J A Papadakis, E S Ganotakis, et al.
Clinical and Experimental Rheumatology|May 29, 2009
High prevalence of metabolic syndrome and cardiovascular risk factors in men with ankylosing spondylitis on anti-TNFalpha treatment: correlation with disease activityJ A Papadakis, P I Sidiropoulos, S A Karvounaris, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Current Medicinal Chemistry|July 14, 2007
Dyslipidemia as a risk factor for erectile dysfunctionG E Vrentzos, K I Paraskevas, D P Mikhailidis
Current Pharmaceutical Design|October 8, 2003
The effects of antihypertensive therapy on haemostatic parametersE S Ganotakis, J A Papadakis, G E Vrentzos, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|February 8, 2005
Wild chamomile (Matricaria recutita L.) mouthwashes in methotrexate-induced oral mucositisE E Mazokopakis, G E Vrentzos, J A Papadakis, et al.
Journal of Human Nutrition and Dietetics : the Official Journal of the British Dietetic Association|March 15, 2006
Serum homocysteine concentration as a marker of nutritional status of healthy subjects in Crete, GreeceG E Vrentzos, J A Papadakis, N Malliaraki, et al.
International Journal of Clinical Practice|September 20, 2007
Predicting coronary heart disease risk using the Framingham and PROCAM equations in dyslipidaemic patients without overt vascular diseaseG E Vrentzos, J A Papadakis, E S Ganotakis, et al.
Clinical and Experimental Rheumatology|May 29, 2009
High prevalence of metabolic syndrome and cardiovascular risk factors in men with ankylosing spondylitis on anti-TNFalpha treatment: correlation with disease activityJ A Papadakis, P I Sidiropoulos, S A Karvounaris, et al.
Pageof 1